https://eutils.ncbi.nlm.nih.gov/entrez/eutils/efetch.fcgi?db=pubmed&id=18537687&retmode=xml&tool=Litmetric&email=readroberts32@gmail.com&api_key=61f08fa0b96a73de8c900d749fcb997acc09 185376872008072420190907
1873-4294892008Current topics in medicinal chemistryCurr Top Med ChemDiscovery of structurally diverse nonsteroidal SPRMs based on a screening hit, 1,2-dihydro-2,2,4-trimethyl-6-phenylquinolinone.766780766-80Synthetic steroidal progestins and antiprogestins have been widely used for decades to treat many gynecological conditions. The concept of selective progesterone receptor modulators (SPRMs) has been developed in recent years to design new therapeutic agents that have desirable PR modulating activity with significantly reduced side-effects or increased safety margin. This review describes medicinal chemistry progress of multiple nonsteroidal SPRM series based on a screening hit, 1,2-dihydro-2,2,4-trimethyl-6-phenylquinolinone.ZhiLinLDiscovery Research, Ligand Pharmaceuticals Inc., 10275 Science Center Drive, San Diego, CA 92121, USA. lzhi@ligand.comengJournal ArticleReview
United Arab EmiratesCurr Top Med Chem1011196731568-026601,2-dihydro-2,2,4-trimethyl-6-phenylquinolinone0Quinolones0Receptors, Progesterone4G7DS2Q64YProgesteroneIMHumansProgesteroneanalogs & derivativesQuinoloneschemistrypharmacologytherapeutic useReceptors, Progesteronedrug effectsStructure-Activity Relationship49
200861090200872590200861090ppublish1853768710.2174/156802608784535020